ReGen Biologics, Inc. Announces 510(k) Regulatory Submission In U.S

FRANKLIN LAKES, N.J.--(BUSINESS WIRE)--Jan. 3, 2006--ReGen Biologics, Inc. (OTC: RGBI) announced today the submission on December 28, 2005 of a 510(k) premarket notification to the FDA for its collagen scaffold device. FDA clearance of this 510(k) submission would allow ReGen to market in the U.S. the ReGen(R) family of collagen scaffold products, including an application of the ReGen collagen scaffold for the meniscus.

MORE ON THIS TOPIC